Gujarat Themis Biosyn Ltd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation processBusiness Overview Company manufactures pharmaceuticals and medicinal chemicals. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary). GTBL entered into Technical & Financial collaboration with Yuhan Corporation, South Korea, and...
Gujarat Themis Biosyn's promoter, Themis Medicare, announced a significant development regarding its shareholding. 0.165 Cr equity shares of Gujarat Themis Biosyn, representing 1.51% of its total share capital, were unpledged on July 8. Post-release, Themis Medicare now holds zero pledged shares in Gujarat Themis Biosyn. This move is generally positive...
Promoter Pharmaceutical Business Group (India) Limited has released a significant block of Gujarat Themis Biosyn Limited shares from pledge. A total of 2.545 Cr shares (25.45 lakh shares) were unpledged on July 8, 2026. This transaction substantially reduces the promoter's encumbered holding to just 5,000 shares, down from 25.50 lakh...
Themis Medicare Limited, a promoter of Gujarat Themis Biosyn, pledged 2.50 lakh equity shares of Gujarat Themis Biosyn Limited on January 29, 2026. This transaction, representing 0.23% of Gujarat Themis Biosyn's total share capital, was done to secure an existing borrowing of Rs. 10 crores from Jio Credit Limited. The...
Themis Medicare Limited, a promoter of Gujarat Themis Biosyn Limited, has pledged an additional 1,30,000 equity shares (0.14% of total share capital) of Gujarat Themis Biosyn. This pledge is against an existing Rs 10 Cr borrowing from Jio Credit Limited, aimed at repaying high-interest loans and reducing overall finance costs....
Themis Medicare Limited, a promoter of Gujarat Themis Biosyn Limited, has pledged an additional 3,50,000 equity shares of Gujarat Themis Biosyn Limited. This move secures an existing Rs. 10 crore borrowing from Jio Credit Limited, primarily aimed at repaying high-interest loans and reducing overall finance costs. Post-transaction, Themis Medicare Limited's...
